Sfoglia per Autore
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study
2005-01-01 BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors
2006-01-01 F. LEONE; G. CAVALLONI; M. GUNETTI; Y. PIGNOCHINO; W. PIACIBELLO; M. AGLIETTA
Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions
2006-01-01 GAMMAITONI L; LUCCHI S; BRUNO S; TESIO M; GUNETTI M; PIGNOCHINO Y; MIGLIARDI G; LAZZARI L; AGLIETTA M; REBULLA P; PIACIBELLO W
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma
2006-01-01 F. LEONE; G. CAVALLONI; Y. PIGNOCHINO; I. SAROTTO; R. FERRARIS; V. PIACIBELLO; T. VENESIO; L. CAPUSSOTTI; M. RISIO; M. AGLIETTA
Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice
2006-01-01 TIMEUS F; CRESCENZIO N; SANAVIO F; FAZIO L; DORIA A; FOGLIA L; PIGNOCHINO Y; BERGER M; PIACIBELLO W; MADON E; CORDERO DI MONTEZEMOLO L; FAGIOLI F
Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma
2007-01-01 LEONE F; PIGNOCHINO Y; CAVALLONI G; AGLIETTA M
Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors
2008-01-01 TESIO M; GAMMAITONI L; GUNETTI M; LEUCI V; PIGNOCHINO Y; JORDANEY N; CAPELLERO S; CAMMARATA C; CAIONE L; MIGLIARETTI G; FAGIOLI F; TABILIO A; AGLIETTA M; PIACIBELLO W
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab
2008-01-01 Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
2009-01-01 Pignochino Y; Grignani G; Cavalloni G; Motta M; Tapparo Ml; Bruno S; Bottos A; Gammaitoni L; Migliardi G; Camussi G; Aberghini M; Torchio B; Ferrari S; Bussolino F; Fagioli F; Picci P; Aglietta M
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
2010-01-01 Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F.
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
2011-01-01 Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
2012-01-01 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers.
2012-01-01 Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D.
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma
2013-01-01 Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients
2013-01-01 Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features.
2013-01-01 Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma.
2013-01-01 Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature.
2013-01-01 Galizia D; Palesandro E; Nuzzo AM; Pignochino Y; Aliberti S; Aglietta M; Grignani G.
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study | 2005 | BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F | |
| Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors | 2006 | F. LEONE; G. CAVALLONI; M. GUNETTI; Y. PIGNOCHINO; W. PIACIBELLO; M. AGLIETTA | |
| Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions | 2006 | GAMMAITONI L; LUCCHI S; BRUNO S; TESIO M; GUNETTI M; PIGNOCHINO Y; MIGLIARDI G; LAZZARI L; AGLIETTA M; REBULLA P; PIACIBELLO W | |
| Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma | 2006 | F. LEONE; G. CAVALLONI; Y. PIGNOCHINO; I. SAROTTO; R. FERRARIS; V. PIACIBELLO; T. VENESIO; L. CAPUSSOTTI; M. RISIO; M. AGLIETTA | |
| Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice | 2006 | TIMEUS F; CRESCENZIO N; SANAVIO F; FAZIO L; DORIA A; FOGLIA L; PIGNOCHINO Y; BERGER M; PIACIBELLO W; MADON E; CORDERO DI MONTEZEMOLO L; FAGIOLI F | |
| Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma | 2007 | LEONE F; PIGNOCHINO Y; CAVALLONI G; AGLIETTA M | |
| Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors | 2008 | TESIO M; GAMMAITONI L; GUNETTI M; LEUCI V; PIGNOCHINO Y; JORDANEY N; CAPELLERO S; CAMMARATA C; CAIONE L; MIGLIARETTI G; FAGIOLI F; TABILIO A; AGLIETTA M; PIACIBELLO W | |
| Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab | 2008 | Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F | |
| Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways | 2009 | Pignochino Y; Grignani G; Cavalloni G; Motta M; Tapparo Ml; Bruno S; Bottos A; Gammaitoni L; Migliardi G; Camussi G; Aberghini M; Torchio B; Ferrari S; Bussolino F; Fagioli F; Picci P; Aglietta M | |
| Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas | 2010 | Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F. | |
| Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. | 2011 | Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M. | |
| Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
| A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. | 2012 | Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M. | |
| Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. | 2012 | Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D. | |
| Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma | 2013 | Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca | |
| Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients | 2013 | Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca | |
| Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. | 2013 | Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
| The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. | 2013 | Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G | |
| Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature. | 2013 | Galizia D; Palesandro E; Nuzzo AM; Pignochino Y; Aliberti S; Aglietta M; Grignani G. | |
| Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile